Euroapi SAS is a France-based company. The Company is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. It offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. The Company also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. It has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
Company Information
About this company
Key people
David Seignolle
Chief Executive Officer
Olivier Falut
Chief Financial Officer
Emmanuel L.R. Blin
Non-Executive Independent Chairman of the Board
Jean-Yves Caminade
Non-Executive Director - Representative of Bpifrance Investissement
Olivier Klaric
Non-Executive Director - Representative of Sanofi Aventis Participations
Geraldine Leveau
Non-Executive Director
Marie-Isabelle Penet
Non-Executive Director - Representative of Employees
Click to see more
Key facts
- Shares in issue95.59m
- EPICEAPI
- ISINFR0014008VX5
- LocationFrance
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap€208.39m
- Employees3,428
- ExchangeEuronext Paris
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.